A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin (Record no. 29619515)

MARC details
000 -LEADER
fixed length control field 01604 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518034641.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201911s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1179-190X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s40259-019-00352-7
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wu, Xiaoyun
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20191118
245 00 - TITLE STATEMENT
Title A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Date of publication, distribution, etc. Jun 2019
300 ## - PHYSICAL DESCRIPTION
Extent 335-342 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Area Under Curve
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biosimilar Pharmaceuticals
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Healthy Volunteers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infusions, Intravenous
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Plasma
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutic Equivalency
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wynne, Chris
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xu, Chenchao
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gan, Yiting
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Chaohe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomas, Bert E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yu, Jin-Chen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Shengfeng
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhang, Li
773 0# - HOST ITEM ENTRY
Title BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Related parts vol. 33
-- no. 3
-- p. 335-342
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s40259-019-00352-7">https://doi.org/10.1007/s40259-019-00352-7</a>
Public note Available from publisher's website

No items available.